Grace L. Guo

Associate Professor
Toxicology
Environmental and Occupational Health Sciences Institute
United States of America

Professor Toxicology
Biography

Dr. Guo is an Associate Professor at the Department Pharmacology and Toxicology in the Ernest Mario School of Pharmacy of Rutgers University. She is an adjunct faculty of the Department of Pharmacology, Toxicology and Therapeutics in School of Medicine at the University of Kanas Medical Center. Dr. Guo obtained her MBBS degree from the West China University of Medical Sciences in 1993 and a PhD degree from the University of Kansas Medical Center in 2001, as well as post-doctoral training at the NCI, NIH in 2004. From 2004-2012, Dr. Guo has served as a faculty at the University of Kansas Medical Center.

Research Intrest

Toxicology

List of Publications
Chow, MD, Lee, YH, Guo, GL. The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Mol. Aspects Med. 2017;56 :34-44. doi: 10.1016/j.mam.2017.04.004. PubMed PMID:28442273
Byun, S, Kim, YC, Zhang, Y, Kong, B, Guo, G, Sadoshima, J, Ma, J, Kemper, B, Kemper, JK. A postprandial FGF19-SHP-LSD1 regulatory axis mediates epigenetic repression of hepatic autophagy. EMBO J. 2017;36 (12):1755-1769. doi: 10.15252/embj.201695500. PubMed PMID:28446510 PubMed Central PMC5470039
Guo, GL. Why is the female population more susceptible to cholestasis-induced liver injury-Could it be long noncoding RNA H19?. Hepatology. 2017;66 (3):694-696. doi: 10.1002/hep.29255. PubMed PMID:28508397
Zheng, Z, Zhao, Z, Li, S, Lu, X, Jiang, M, Lin, J, An, Y, Xie, Y, Xu, M, Shen, W et al.. Altenusin, a non-steroidal microbial metabolite, attenuates non-alcoholic fatty liver disease by activating the farnesoid X receptor. Mol. Pharmacol. 2017; :. doi: 10.1124/mol.117.108829. PubMed PMID:28739572
Green, AL, Zhan, L, Eid, A, Zarbl, H, Guo, GL, Richardson, JR. Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1. Neuropharmacology. 2017;125 :189-196. doi: 10.1016/j.neuropharm.2017.07.020. PubMed PMID:28743636